Literature DB >> 19138047

Thyroid nodules, polymorphic variants in DNA repair and RET-related genes, and interaction with ionizing radiation exposure from nuclear tests in Kazakhstan.

Alice J Sigurdson1, Charles E Land, Parveen Bhatti, Marbin Pineda, Alina Brenner, Zhanat Carr, Boris I Gusev, Zhaxibay Zhumadilov, Steven L Simon, Andre Bouville, Joni L Rutter, Elaine Ron, Jeffery P Struewing.   

Abstract

Risk factors for thyroid cancer remain largely unknown except for ionizing radiation exposure during childhood and a history of benign thyroid nodules. Because thyroid nodules are more common than thyroid cancers and are associated with thyroid cancer risk, we evaluated several polymorphisms potentially relevant to thyroid tumors and assessed interaction with ionizing radiation exposure to the thyroid gland. Thyroid nodules were detected in 1998 by ultrasound screening of 2997 persons who lived near the Semipalatinsk nuclear test site in Kazakhstan when they were children (1949-1962). Cases with thyroid nodules (n = 907) were frequency matched (1:1) to those without nodules by ethnicity (Kazakh or Russian), gender and age at screening. Thyroid gland radiation doses were estimated from fallout deposition patterns, residence history and diet. We analyzed 23 polymorphisms in 13 genes and assessed interaction with ionizing radiation exposure using likelihood ratio tests (LRT). Elevated thyroid nodule risks were associated with the minor alleles of RET S836S (rs1800862, P = 0.03) and GFRA1 -193C>G (rs not assigned, P = 0.05) and decreased risk with XRCC1 R194W (rs1799782, P trend = 0.03) and TGFB1 T263I (rs1800472, P = 0.009). Similar patterns of association were observed for a small number of papillary thyroid cancers (n = 25). Ionizing radiation exposure to the thyroid gland was associated with significantly increased risk of thyroid nodules (age and gender adjusted excess odds ratio/Gy = 0.30, 95% CI 0.05-0.56), with evidence for interaction by genotype found for XRCC1 R194W (LRT P value = 0.02). Polymorphisms in RET signaling, DNA repair and proliferation genes may be related to risk of thyroid nodules, consistent with some previous reports on thyroid cancer. Borderline support for gene-radiation interaction was found for a variant in XRCC1, a key base excision repair protein. Other pathways such as genes in double-strand break repair, apoptosis and genes related to proliferation should also be pursued.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19138047      PMCID: PMC2875679          DOI: 10.1667/RR1327.1

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  33 in total

1.  Familial occurrence of nonmedullary thyroid cancer: a population-based study of 5673 first-degree relatives of thyroid cancer patients from Norway.

Authors:  L Frich; E Glattre; L A Akslen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2001-02       Impact factor: 4.254

Review 2.  Somatic and germline mutations of the TSH receptor and thyroid diseases.

Authors:  B Corvilain; J Van Sande; J E Dumont; G Vassart
Journal:  Clin Endocrinol (Oxf)       Date:  2001-08       Impact factor: 3.478

3.  Fallout from nuclear tests: health effects in Kazakhstan.

Authors:  B Grosche; C Land; S Bauer; L M Pivina; Z N Abylkassimova; B I Gusev
Journal:  Radiat Environ Biophys       Date:  2002-03       Impact factor: 1.925

4.  Ultrasound-detected thyroid nodule prevalence and radiation dose from fallout.

Authors:  C E Land; Z Zhumadilov; B I Gusev; M H Hartshorne; P W Wiest; P W Woodward; L A Crooks; N K Luckyanov; C M Fillmore; Z Carr; G Abisheva; H L Beck; A Bouville; J Langer; R Weinstock; K I Gordeev; S Shinkarev; S L Simon
Journal:  Radiat Res       Date:  2008-04       Impact factor: 2.841

5.  A pooled analysis of case-control studies of thyroid cancer. IV. Benign thyroid diseases.

Authors:  S Franceschi; S Preston-Martin; L Dal Maso; E Negri; C La Vecchia; W J Mack; A McTiernan; L Kolonel; S D Mark; K Mabuchi; F Jin; G Wingren; R Galanti; A Hallquist; E Glattre; E Lund; F Levi; D Linos; E Ron
Journal:  Cancer Causes Control       Date:  1999-12       Impact factor: 2.506

6.  Multilevel modeling in epidemiology with GLIMMIX.

Authors:  J S Witte; S Greenland; L L Kim; L Arab
Journal:  Epidemiology       Date:  2000-11       Impact factor: 4.822

7.  Over-representation of a germline variant in the gene encoding RET co-receptor GFRalpha-1 but not GFRalpha-2 or GFRalpha-3 in cases with sporadic medullary thyroid carcinoma.

Authors:  O Gimm; H Dziema; J Brown; C Hoang-Vu; R Hinze; H Dralle; L M Mulligan; C Eng
Journal:  Oncogene       Date:  2001-04-19       Impact factor: 9.867

8.  Specific haplotypes of the RET proto-oncogene are over-represented in patients with sporadic papillary thyroid carcinoma.

Authors:  F Lesueur; M Corbex; J D McKay; J Lima; P Soares; P Griseri; J Burgess; I Ceccherini; S Landolfi; M Papotti; A Amorim; D E Goldgar; G Romeo
Journal:  J Med Genet       Date:  2002-04       Impact factor: 6.318

9.  Increased risk for nonmedullary thyroid cancer in the first degree relatives of prevalent cases of nonmedullary thyroid cancer: a hospital-based study.

Authors:  T Pal; F D Vogl; P O Chappuis; R Tsang; J Brierley; H Renard; K Sanders; T Kantemiroff; S Bagha; D E Goldgar; S A Narod; W D Foulkes
Journal:  J Clin Endocrinol Metab       Date:  2001-11       Impact factor: 5.958

10.  Extracellular signaling through the microenvironment: a hypothesis relating carcinogenesis, bystander effects, and genomic instability.

Authors:  M H Barcellos-Hoff; A L Brooks
Journal:  Radiat Res       Date:  2001-11       Impact factor: 2.841

View more
  16 in total

Review 1.  Exposing the thyroid to radiation: a review of its current extent, risks, and implications.

Authors:  Bridget Sinnott; Elaine Ron; Arthur B Schneider
Journal:  Endocr Rev       Date:  2010-07-21       Impact factor: 19.871

Review 2.  Second malignant neoplasms and cardiovascular disease following radiotherapy.

Authors:  Lois B Travis; Andrea K Ng; James M Allan; Ching-Hon Pui; Ann R Kennedy; X George Xu; James A Purdy; Kimberly Applegate; Joachim Yahalom; Louis S Constine; Ethel S Gilbert; John D Boice
Journal:  J Natl Cancer Inst       Date:  2012-02-06       Impact factor: 13.506

3.  First survey of the two polymorphisms (Arg194Trp and Arg399Gln) in XRCC1 gene in four Afghanistan populations and comparison with worldwide data.

Authors:  Khyber Saify; Iraj Saadat; Mostafa Saadat
Journal:  Mol Biol Rep       Date:  2013-05-22       Impact factor: 2.316

4.  Association between the XRCC1 Arg194Trp polymorphism and risk of cancer: evidence from 201 case-control studies.

Authors:  Yan-Zhong Feng; Yi-Ling Liu; Xiao-Feng He; Wu Wei; Xu-Liang Shen; Dao-Lin Xie
Journal:  Tumour Biol       Date:  2014-07-27

5.  Association between XRCC1 and XRCC3 gene polymorphisms and risk of thyroid cancer.

Authors:  Xufu Wang; Kunpeng Zhang; Xinfeng Liu; Bin Liu; Zhenguang Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

Review 6.  The State Scientific Automated Medical Registry, Kazakhstan: an important resource for low-dose radiation health research.

Authors:  K N Apsalikov; A Lipikhina; B Grosche; T Belikhina; E Ostroumova; S Shinkarev; V Stepanenko; T Muldagaliev; S Yoshinaga; T Zhunussova; M Hoshi; H Katayama; D T Lackland; S L Simon; A Kesminiene
Journal:  Radiat Environ Biophys       Date:  2018-11-16       Impact factor: 1.925

Review 7.  Non-malignant thyroid diseases after a wide range of radiation exposures.

Authors:  Elaine Ron; Alina Brenner
Journal:  Radiat Res       Date:  2010-09-07       Impact factor: 2.841

8.  Neuroendocrine Merkel cell carcinoma is associated with mutations in key DNA repair, epigenetic and apoptosis pathways: a case-based study using targeted massively parallel sequencing.

Authors:  Christian A Graves; Ashley Jones; Justin Reynolds; Jeremy Stuart; Lucia Pirisi; Peter Botrous; James Wells
Journal:  Neuroendocrinology       Date:  2014-12-11       Impact factor: 4.914

9.  Accounting for shared and unshared dosimetric uncertainties in the dose response for ultrasound-detected thyroid nodules after exposure to radioactive fallout.

Authors:  Charles E Land; Deukwoo Kwon; F Owen Hoffman; Brian Moroz; Vladimir Drozdovitch; André Bouville; Harold Beck; Nicholas Luckyanov; Robert M Weinstock; Steven L Simon
Journal:  Radiat Res       Date:  2015-01-09       Impact factor: 2.841

10.  Association of XRCC1 polymorphisms with thyroid cancer risk.

Authors:  Cong Wang; Zhilong Ai
Journal:  Tumour Biol       Date:  2014-01-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.